What is the NAMED PATIENT PROGRAM? How It Helps Patients Access Lifesaving Treatments
Learn how patients can legally access international medications through a regulated pathway.
Read Full Blog →
Step-by-Step Guide: How the Named Patient Program Works at MitoGENE
A complete walkthrough of the patient journey from first inquiry to medicine delivery with clear timelines.
Read Full Blog →
Breakthrough Advanced Therapies You Can Access Through the Named Patient Program
How Indian patients can legally access breakthrough global therapies when treatments are not available locally.
Read Full Blog →
LUNG CANCER – AVAILABILITY AND ACCESS
Access to advanced lung cancer medicines through India’s Named Patient Program with MitoGENE support.
Read Full Blog →
BREAST CANCER – AVAILABILITY AND ACCESS
How advanced breast cancer patients may access select global therapies through the Named Patient Program.
Read Full Blog →
SOLID TUMORS – AVAILABILITY AND ACCESS
Understanding solid tumor treatment access through Named Patient Programs, including availability and regulatory pathways.
Read Full Blog →
HEMATOLOGY – AVAILABILITY AND ACCESS
When standard blood cancer treatments are no longer suitable, India’s Named Patient Program may enable regulated access.
Read Full Blog →
Enabling Access to LUMAKRAS in India for KRAS G12C–Positive Lung Cancer
Access to LUMAKRAS through the CDSCO Named Patient Program under oncologist supervision.
Read Full Blog →
Accessing IMDELLTRA for Advanced Lung Cancer Through India’s Named Patient Program
Structured regulatory guidance ensured safe, compliant import and timely treatment initiation.
Read Full Blog →
Facilitating Libtayo Access for PD-L1–Positive NSCLC in India
Structured Named Patient Program enabled access to critical immunotherapy despite local unavailability.
Read Full Blog →
Accessing DATROWAY in India for Advanced Breast Cancer through NAMED PATIENT PROGRAM
Legal and safe access to the advanced breast cancer therapy DATROWAY in India was enabled through the CDSCO Named Patient Program with complete support from MitoGENE.
Read Full Blog →
Enabling Access to Orserdu for Endocrine-Resistant Breast Cancer in India
Access to Orserdu in India was enabled through the Named Patient Program, supporting treatment for endocrine-resistant breast cancer and improving continuity of care.
Read Full Blog →
Accessing Truqap (Capivasertib) in India for Advanced Breast Cancer
Accessing Truqap (Capivasertib) in India for an advanced breast cancer patient through the CDSCO-compliant Named Patient Program with end-to-end support by MitoGENE.
Read Full Blog →
Accessing VYLOY® (zolbetuximab) for Advanced Gastric Cancer in India via Named Patient Program
How an advanced gastric cancer patient in India accessed VYLOY® (zolbetuximab) through the Named Patient Program with regulatory support from MitoGENE.
Read Full Blog →